Yes Skint I agree. While not popular here, I posted information about SRPT because I believe that situation has had a profound effect on the FDA neurology board and caused way too much political angst within the agency. The backlash is now in effect. EMA is much more plausible.
Ann: Prana provides regulatory update for PBT2-PBT.AX, page-31
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $1.633K | 487.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 32189472 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126368541 | 15 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |